Impact of Disease-Modifying Treatments on the Longitudinal Evolution of Anti-JCV Antibody Index in Multiple Sclerosis

Background: Risk of natalizumab-related progressive multifocal leukoencephalopathy is associated with the presence of anti-JC-virus (JCV) antibodies. Objective: To investigate the impact of disease-modifying treatments (DMT) on the longitudinal evolution of anti-JCV antibody index. Methods: Patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Hegen, Harald, Walde, Janette, Bsteh, Gabriel, Auer, Michael, Wurth, Sebastian, Zinganell, Anne, Di Pauli, Franziska, Deisenhammer, Florian, Berger, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6209669/
https://ncbi.nlm.nih.gov/pubmed/30410486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02435
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados